David E. Kandzari, M.D.
Director, Interventional Cardiology and Research, Piedmont Heart Institute
Former CMO, Johnson & Johnson’s Cordis Cardiology Unit
Former Medical Officer, FDA’s Center for Devices and Radiological Health
David E. Kandzari, M.D. earned his undergraduate degree from Duke University School of Medicine and completed his internship and residency at The John Hopkins University School of Medicine. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences.
Dr. Kandzari is the former director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. Additionally, he has served as a medical officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration and is currently an ad hoc member of the FDA’s Circulatory Devices Panel.
Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews and has delivered more than 300 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology.
Dr. Kandzari is board certified in internal medicine and cardiovascular diseases and certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His clinical focus includes catheter-based revascularization of complex coronary and peripheral disease.